These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23884841)

  • 1. PET/CT imaging of skeletal muscle metastases.
    Surov A; Pawelka MK; Wienke A; Schramm D
    Acta Radiol; 2014 Feb; 55(1):101-6. PubMed ID: 23884841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple and solitary skeletal muscle metastases on 18F-FDG PET/CT imaging.
    Nocuń A; Chrapko B
    Nucl Med Commun; 2015 Nov; 36(11):1091-9. PubMed ID: 26275016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle metastases on FDG PET/CT imaging.
    Khandelwal AR; Takalkar AM; Lilien DL; Ravi A
    Clin Nucl Med; 2012 Jun; 37(6):575-9. PubMed ID: 22614189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of skeletal muscle metastasis: torso FDG PET-CT versus contrast-enhanced chest or abdomen CT.
    So Y; Yi JG; Song I; Lee WW; Chung HW; Park JH; Moon SG
    Acta Radiol; 2015 Jul; 56(7):860-6. PubMed ID: 25406434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple muscle metastases from lung cancer detected by FDG PET/CT.
    Yilmaz M; Elboga U; Celen Z; Isik F; Tutar E
    Clin Nucl Med; 2011 Mar; 36(3):245-7. PubMed ID: 21285692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
    Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
    J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular metastases on FDG PET-CT: a review of the literature.
    Emmering J; Vogel WV; Stokkel MP
    Nucl Med Commun; 2012 Feb; 33(2):117-20. PubMed ID: 22124361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of radiological and hybrid imaging for muscle metastases: a systematic review.
    Lupi A; Weber M; Del Fiore P; Rastrelli M; Guglielmi G; Stramare R; Quaia E; Cecchin D; Giraudo C
    Eur Radiol; 2020 Apr; 30(4):2209-2219. PubMed ID: 31834507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple distant muscular metastases from non-small cell lung carcinoma evidenced by 18F-FDG PET/CT.
    Caobelli F; Pizzocaro C; Guerra UP
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):338-9. PubMed ID: 23809515
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysplenia Syndrome With Splenic and Skeletal Muscle Metastases From Thyroid Carcinoma Evaluated by FDG PET/CT: Case Report and Literature Review: A Care-Compliant Article.
    Li ZG; Lin ZC; Mu HY
    Medicine (Baltimore); 2016 Jan; 95(4):e2532. PubMed ID: 26825891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: potential value in the clinic.
    Li L; Ren S; Zhang Y; Guan Y; Zhao J; Liu J; Wang Q; Chen G; Chen H; Xiang J; Fu X
    Lung Cancer; 2013 Aug; 81(2):213-7. PubMed ID: 23664030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
    Hu M; Li MH; Kong L; Liu NB; Yang GR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):699-701. PubMed ID: 19173915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastases of esophageal carcinoma to skeletal muscle: single center experience.
    Cincibuch J; Mysliveček M; Melichar B; Neoral C; Metelková I; Zezulová M; Procházková-Študentová H; Flodr P; Zlevorová M; Aujeský R; Cwiertka K
    World J Gastroenterol; 2012 Sep; 18(35):4962-6. PubMed ID: 23002370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer.
    Sachs S; Bilfinger TV; Komaroff E; Franceschi D
    Clin Lung Cancer; 2005 Mar; 6(5):310-3. PubMed ID: 15845183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic Thyroid Cancer With Extensive Skeletal Muscle Metastases on 18F-FDG PET/CT.
    Yurkiewicz IR; Ganjoo KN; Iagaru A
    Clin Nucl Med; 2018 Apr; 43(4):e113-e114. PubMed ID: 29356736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer.
    Zhang H; Wroblewski K; Pu Y
    Acta Radiol; 2012 Jun; 53(5):561-8. PubMed ID: 22661603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.